{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-116666","form_type":"8-K","ticker":"ADIL","cik":"0001513525","company_name":"ADIAL PHARMACEUTICALS, INC.","filed_at":"2025-12-01T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.599318+00:00","generated_at":"2026-05-16T15:52:36.704550+00:00","sec_items":["1.01","3.02","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Adial Pharmaceuticals raises $2.86M via warrant inducement; issues new Series F warrants for up to 13.8M shares","bullets":["Holder exercised 9,215,675 existing Series C-1 and E warrants at $0.31/share, generating gross proceeds of $2.86M.","In consideration, company issued new unregistered Series F warrants to purchase up to 13,823,512 shares at $0.31.","New warrants exercisable only after stockholder approval, term 24 months from approval date; company must seek approval within 120 days of closing.","Company agreed to 60-day standstill on equity issuances (except ATM after 31 days) and 6-month no variable rate transactions.","A.G.P./Alliance Global Partners acted as financial advisor with an 8% fee on gross proceeds."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-116666","json":"https://secwatch.observer/filing/0001213900-25-116666.json","markdown":"https://secwatch.observer/filing/0001213900-25-116666.md","text":"https://secwatch.observer/filing/0001213900-25-116666.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1513525/000121390025116666/0001213900-25-116666-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1513525/000121390025116666/ea0267799-8k_adial.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T15:52:36.704550+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"a53b6847be70759076cca7f656f6013bbc79bff9","claim":"ADIAL PHARMACEUTICALS, INC. issued up to 13,823,512 shares of Common Stock of warrant to the Holder.","evidence_excerpt":"In consideration of the Holder’s immediate exercise of the Existing Warrants in accordance with the Inducement Agreement, the Company issued unregistered Series F Common Stock Purchase Warrants (the “New Warrants”) to purchase up to 13,823,512 shares of Common Stock (the “New Warrant Shares”).","evidence_source":"SEC 8-K Item 3.02/3.03","evidence_url":"https://www.sec.gov/Archives/edgar/data/1513525/000121390025116666/0001213900-25-116666-index.htm","confidence":0.9,"family_label":"Equity Issuances","details":[{"label":"Security","value":"warrant"},{"label":"Shares","value":"up to 13,823,512 shares of Common Stock"},{"label":"Purchaser","value":"the Holder"}],"fact_type":"equity_issuance"},{"claim_id":"f59a56cb9ec3a34d274dd522e40212501a41dd87","claim":"ADIAL PHARMACEUTICALS, INC. entered into Inducement Agreement with a certain holder named therein valued at approximately $2.86 million (effective 2025-11-25).","evidence_excerpt":"On November 25, 2025, Adial Pharmaceuticals, Inc. (the “Company”) entered into a warrant inducement agreement (the “Inducement Agreement”) with a certain holder named therein (the “Holder”) of Series C-1 Common Stock Purchase Warrants to purchase up to 4,025,000 shares of the Company’s common stock","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1513525/000121390025116666/0001213900-25-116666-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"a certain holder named therein"},{"label":"Value","value":"approximately $2.86 million"},{"label":"Effective","value":"2025-11-25"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}